✦ LIBER ✦

Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B

✍ Scribed by Karen F. Murray; Leszek Szenborn; Jacek Wysocki; Stephen Rossi; Amoreena C. Corsa; Phillip Dinh; John McHutchison; Phillip S. Pang; Luminita M. Luminos; Malgorzata Pawlowska; Jacek Mizerski

Book ID: 115556295
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 526 KB
Volume: 56
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.25818

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

533 RANDOMIZED, PLACEBO-CONTROLLED TRIAL

533 RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF TENOFOVIR DF IN ADOLESCENTS WITH CHRONIC HEPATITIS B

✍ K.F. Murray; L. Szenborn; J. Wysocki; S. Rossi; A.C. Corsa; P. Dinh; J.G. McHutc 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Randomized Comparison of Tenofovir Disop

Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B

✍ Fung, Scott; Kwan, Peter; Fabri, Milotka; Horban, Andrzej; Pelemis, Mijomir; Han 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 639 KB

Tenofovir disoproxil fumarate in the tre

Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B

✍ Jenh, Alice M ;Pham, Paul A 📂 Article 📅 2010 🏛 Expert Reviews 🌐 English ⚖ 958 KB

Tenofovir disoproxil fumarate in the tre

Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B

✍ Buti, Maria; Homs, Maria 📂 Article 📅 2012 🏛 Expert Reviews 🌐 English ⚖ 973 KB

Cost–Utility Analysis of Tenofovir Disop

Cost–Utility Analysis of Tenofovir Disoproxil Fumarate in the Treatment of Chronic Hepatitis B

✍ Helen Dakin; Anthony Bentley; Geoff Dusheiko 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB

Tenofovir disoproxil fumarate (TDF), emt

Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease

✍ Yun-Fan Liaw; I-Shyan Sheen; Chuan-Mo Lee; Ulus Salih Akarca; George V. Papatheo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB

Data are limited on the safety and effectiveness of oral antivirals other than lamivudine and adefovir dipivoxil for treatment of chronic hepatitis B (CHB) in patients with decompensated liver disease. This Phase 2, double-blind study randomized 112 patients with CHB and decompensated liver disease